I have no doubt that A2 is taking a big chunk of BALs market share. Remember BAL still contains the A1 protein. A2 is a niche product in a growing market where currently IF demand > supply. Babies in China and around the world are not going to stop being born so demand will only continue to increase. The fundamentals of the company have not changed since last week. IMOO. DYOR etc
Misled and overreacted..., page-62
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.77 |
Change
-0.130(2.20%) |
Mkt cap ! $4.171B | |||
| Open | High | Low | Value | Volume |
| $5.87 | $5.91 | $5.77 | $8.457M | 1.452M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 12297 | $5.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.82 | 7000 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| A2M (ASX) Chart |